Enzymotec to Report First Quarter 2016 Financial Results
May 05 2016 - 7:30AM
Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer and
marketer of innovative bio-active lipid based nutritional
ingredients and medical foods, announced today that the Company
will release financial results for the first quarter ended March
31, 2016 on Thursday, May 19, 2016, before the market opens.
Following the release, Dr. Ariel Katz, President and Chief
Executive Officer, and Oren Bryan, Vice President and Chief
Financial Officer, will host a conference call to review the
financial results.
The conference call is scheduled to begin at 8:30
a.m. ET on Thursday, May 19, 2016. Participants should dial (877)
359-9508 (United States) or (224) 357-2393 (International) with
confirmation code #4029515 to access the live call. The call
will also be broadcast live over the Internet, hosted in the
Investors section of Enzymotec's website
at http://edge.media-server.com/m/p/vx4zfxag, and will be
archived online within one hour of its completion through May 26,
2016.
About Enzymotec Ltd.
Enzymotec is a leading global supplier of specialty lipid-based
products and solutions. The Company develops, manufactures, and
markets innovative bio-active lipid based nutritional ingredients
and medical foods, driven by a deep core of cutting-edge,
proprietary technologies intended to improve people’s health. For
more information, visit www.enzymotec.com.
Contact:
The Ruth Group
Tram Bui / Lee Roth
(646) 536-7035 / 7012
tbui@theruthgroup.com
lroth@theruthgroup.com
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jun 2024 to Jul 2024
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Enzymotec Ltd. - Ordinary Shares (delisted) (NASDAQ): 0 recent articles
More News Articles